Girard Partners’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $5.7M | Buy |
27,594
+97
| +0.4% | +$20K | 0.54% | 47 |
|
|
2024
Q1 | $7.45M | Buy |
27,497
+2,566
| +10% | +$695K | 0.7% | 36 |
|
|
2023
Q4 | $5.89M | Buy |
24,931
+3,175
| +15% | +$751K | 0.6% | 40 |
|
|
2023
Q3 | $4.26M | Buy |
21,756
+1,076
| +5% | +$211K | 0.48% | 50 |
|
|
2023
Q2 | $4.35M | Buy |
+20,680
| New | +$4.35M | 0.46% | 52 |
|